Snapshot

The Project FrontRunner pathway has been developed by the of United States.

This pathway can be used where New cancer drugs for advanced or metastatic disease, in an earlier clinical setting..

This pathway accelerates the regulatory review process.

It is an abridged review (a reliance pathway).

Info not available.